Blood test may spot lung risk in brain injury patients

NCT ID NCT07664358

Recruiting now Diagnosis Sponsor: Tanta University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study looks at whether a simple blood test, called the fibrinogen-to-albumin ratio, can predict if someone with a traumatic brain injury will develop acute respiratory distress syndrome (ARDS), a serious lung condition. Researchers will measure these proteins in the blood of 350 adults admitted to the ICU within 24 hours of injury. The goal is to see if this ratio can help doctors identify high-risk patients early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could give doctors a simple blood test to identify TBI patients at high risk of ARDS, allowing earlier monitoring and treatment.
What could go wrong: This is an observational study, not a treatment trial. The test may not prove accurate enough for routine use, and results may not apply to all hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALBUMIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome Brain Injuries, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALBUMIN ARDS FIBRINOGEN FIBRINOGEN ALBUMIN RATIO TBI (TRAUMATIC BRAIN INJURY)

Contacts and locations

Locations

Tanta University Hospitals
RECRUITING

Tanta, Gharbia Governorate, 31527, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.